Nora Parore

Ms. Nora Parore

Te Hikuwai Rangahau Hauora, Victoria University of Wellington, Wellington, New Zealand
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Open access
CMCaroline Morris
Caroline Morris
JMJanet McDonald
Janet McDonald
TOTara Nikki Officer
Tara Nikki Officer
ATAusaga Fa'ASalele Tanuvasa
Ausaga Fa'ASalele Tanuvasa
KSKirsten Smiler
Kirsten Smiler
JCJacqueline Margaret Cumming
Jacqueline Margaret Cumming
Internationally, community pharmacy models of care have been moving away from a focus on dispensing to extended, clinically-focused roles for pharmacists. To identify how community pharmacy strategies were being implemented in Aotearoa New Zealand; how changes were expected to influence health and health system outcomes; what extended services were being delivered; the responses of pharmacists, other health professionals and consumers to these developments; and the contexts and mechanisms supporting the successful implementation of new community pharmacy services. A realist evaluation methodology was employed, to explore a complex policy intervention. Realist evaluation explores the contexts (C) within which initiatives are introduced and identifies the mechanisms (M) triggered by different contexts to produce outcomes (O). Realist evaluation processes iteratively develop, test, and refine CMO configurations. In this study, initial programme theories were developed through key government and professional policy documents, then refined through key informant interviews, a survey and interviews with pharmacists and intern (pre-registration) pharmacists, and finally, 10 case studies of diverse community pharmacies. Four intermediate health service outcomes were identified: development of extended community pharmacist services; consumers using extended community pharmacist services; more integrated, collaborative primary health care services; and a fit-for-purpose community pharmacy workforce. Enabling and constraining contexts are detailed for each outcome, along with the mechanisms that they trigger (or inhibit). There are wide-ranging and disparate levers to support the further development of extended community pharmacy services. These include aligning funding with desired services, undergraduate educators and professional leaders setting expectations for the pharmacists' role in practice, and the availability of sufficient funding and time for both specific extended service accreditation and broader postgraduate training. However, no simple "fix" can be universally applied internationally, nor even in pharmacies within a single jurisdiction, to facilitate service development.

31 December 2022 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
JHJoanna Hikaka
Joanna Hikaka
RHRobert Haua
Robert Haua
NPNora Parore
Nora Parore
BMBrendon McIntosh
Brendon McIntosh
AAAnneka Anderson
Anneka Anderson
RBRachel Brown
Rachel Brown

LRLynne Russell
Lynne Russell
MLMichelle Levy
Michelle Levy
EBElizabeth Barnao
Elizabeth Barnao
NPNora Parore
Nora Parore
KSKirsten Smiler
Kirsten Smiler
Amohia BoultonAmohia Boulton
Amohia Boulton
Māori, the Indigenous people of Aotearoa (New Zealand), were at the centre of their country’s internationally praised COVID-19 response. This paper, which presents the results of qualitative research conducted with 27 Māori health leaders exploring issues impacting the effective delivery of primary health care services to Māori, reports this response. Against a backdrop of dominant system services closing their doors or reducing capacity, iwi, hapū and rōpū Māori (‘tribal’ collectives and Māori groups) immediately collectivised, to deliver culturally embedded, comprehensive COVID-19 responses that served the entire community. The results show how the exceptional and unprecedented circumstances of COVID-19 provided a unique opportunity for iwi, hapū and rōpū Māori to authentically activate mana motuhake; self-determination and control over one’s destiny. Underpinned by foundational principles of transformative Kaupapa Māori theory, Māori-led COVID-19 responses tangibly demonstrated the outcomes able to be achieved for everyone in Aotearoa when the wider, dominant system was forced to step aside, to be replaced instead with self-determining, collective, Indigenous leadership.

28 August 2022 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
JHJoanna Hikaka
Joanna Hikaka
NPNora Parore
Nora Parore
RHRobert Haua
Robert Haua
AAAnneka Anderson
Anneka Anderson
MHMariana Hudson
Mariana Hudson
RBRachel Brown
Rachel Brown
Medicines are the most common medical intervention and medicines adherence is associated with improved clinical outcomes. Understanding drivers and experiences of medicines adherence is important for optimising medicines use. Māori (Indigenous people of Aotearoa New Zealand) experience inequities in access to medicines yet little evidence exists regarding Māori and medicines adherence, or the role of pharmacists in supporting medicines adherence for Māori. To explore Māori experiences of medicines adherence and non-adherence, and pharmacists' role in supporting adherence. This was a convergent parallel mixed methods study. Facilitated wānanga (collaborative knowledge-sharing group discussions) were undertaken either online or in-person with eligible participants, using convenience and snowball sampling to recruit. Participants were eligible if they were Māori, 18 years or older, and had recently obtained medicine from a pharmacy. Wānanga involved semi-structured interviewing and questionnaire completion. General inductive coding and thematic analysis and descriptive statistical analysis were used respectively, and findings were situated in social, cultural and political Māori contexts. Thirteen wānanga were conducted with 62 participants (71% female, median age range 35–44) from September 2021 to February 2022. Four themes were identified: The aspirations of hauora Māori (Māori wellbeing) - medicines as a component of holistic wellbeing; whanaungatanga (relationships); knowledge; and whānau (family and support network) advocacy and problem solving. Forgetting to take medicines was the most frequently identified reason for non-adherence, followed by not having medicines on hand, adverse effects, and lack of symptoms of health conditions. Participants identified that proactive pharmacist support, including developing caring therapeutic relationships, sharing knowledge, acknowledging medicines as just one component of holistic wellbeing, and giving adherence tips to support routine medicine taking were positive ways that pharmacists could support medicines adherence. Factors contributing to medicines adherence were diverse and participants identified numerous practical solutions that pharmacists, health service providers and policymakers could employ to support Māori medicines adherence.

2 March 2026 in International Journal of Pharmacy Practice
Verified
Journal Article
Open access
JHJoanna Hikaka
Joanna Hikaka
FTFlorence Tauvae Tuiletufuga
Florence Tauvae Tuiletufuga
BMBrendon McIntosh
Brendon McIntosh
LKLisa Kremer
Lisa Kremer
NPNora Parore
Nora Parore
Objectives: Pharmacists are integral to advancing equitable healthcare, implementing culturally safe practices that address power imbalances, racism, and institutional barriers. Ethnicity-based eligibility criteria (EBEC) have improved treatment access in some settings, but little is known about how community pharmacists experience and implement these criteria in practice. This study aimed to explore pharmacists’ perceptions of (i) applying EBEC in community pharmacy; (ii) the extent to which the provision of education or resources would be useful in the future. Methods: A descriptive cross-sectional survey of registered and pre-registrant pharmacists in Aotearoa, New Zealand, was conducted. Participants were recruited via professional and researcher networks, with data collected anonymously using a piloted survey on Qualtrics®. Quantitative responses were analysed with descriptive statistics, and qualitative data were inductively coded and refined through team consensus to identify themes. Key findings: Two hundred and eighteen pharmacists (median age band 36–45 years, median of 20 years pharmacy experience) completed the survey. Although most pharmacists felt comfortable applying EBEC, half felt implementation would have been better supported if training or resources were available. Participants had limited experience discussing ethnicity with patients and wanted to be better equipped to discuss eligibility with those who were eligible, and with those who opposed the use of EBEC. Resources needed to focus on evidence-based justification of EBEC, definitions of ethnicity, and role modelled conversations. Conclusions: When implementing new types of eligibility criteria for community pharmacy services, pharmacists need sufficient and appropriate training and resources for effective implementation.